BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Kyung-Hyun Kim, Kwan-Kyu Park. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are?World Journal of Gastroenterology 2014; 20(40): 14696-14705 doi: 10.3748/wjg.v20.i40.14696
2
Ana Thereza B. Gomes, Carla Guimarães Bastos, Clara L. Afonso, Bruno Frederico Medrado, Zilton A. Andrade. How variable are hydroxyproline determinations made in different samples of the same liver?Clinical Biochemistry 2006; 39(12): 1160 doi: 10.1016/j.clinbiochem.2006.08.002
3
Massimo Pinzani, Krista Rombouts, Stefano Colagrande. Fibrosis in chronic liver diseases: diagnosis and managementJournal of Hepatology 2005; 42(1): S22 doi: 10.1016/j.jhep.2004.12.008
4
Shi-zhang Wei, Sheng-qiang Luo, Jian Wang, Jia-bo Wang, Rui-sheng Li, Xiao-mei Zhang, Yan-lei Guo, Chang Chen, Xiao Ma, Zhe Chen, Hong-hong Liu, Zhi-rui Yang, Jian-yu Li, Rui-lin Wang, Ya-ming Zhang, Hui-yin Yang, Xiao-he Xiao, Yan-ling Zhao. San-Cao Granule (三草颗粒) Ameliorates Hepatic Fibrosis through High Mobility Group Box-1 Protein/Smad Signaling PathwayChinese Journal of Integrative Medicine 2018; 24(7): 502 doi: 10.1007/s11655-015-2127-0
5
Mabrouk A. Abo‐Zaid, Emad S. Shaheen, Ahmed H. Ismail. Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental ratsJournal of Food Biochemistry 2020; 44(6) doi: 10.1111/jfbc.13219
6
Hui Chen, Yong-Wen He, Wen-Qi Liu, Jing-Hui Zhang. Rosiglitazone prevents murine hepatic fibrosis induced by <italic>Schistosoma japonicum</italic>World Journal of Gastroenterology 2008; 14(18): 2905-2911 doi: 10.3748/wjg.14.2905
7
Zuojiong Gong, Shaonan Yan, Ping Zhang, Yanqing Huang, Luwen Wang. Effects of S-adenosylmethionine on liver methionine metabolism and steatosis with ethanol-induced liver injury in ratsHepatology International 2008; 2(3): 346 doi: 10.1007/s12072-008-9082-1
8
Shi-Lin Du, Hong Pan, Wei-Yue Lu, Jian Wang, Jian Wu, Ji-Yao Wang. Cyclic Arg-Gly-Asp Peptide-Labeled Liposomes for Targeting Drug Therapy of Hepatic Fibrosis in RatsJournal of Pharmacology and Experimental Therapeutics 2007; 322(2): 560 doi: 10.1124/jpet.107.122481
9
Zhengping Zhang, Zhongfei Gao, Wei Hu, Shan Yin, Chunming Wang, Yuhui Zang, Jiangning Chen, Junfeng Zhang, Lei Dong. 3,3′-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expressionBritish Journal of Pharmacology 2013; 170(3): 649 doi: 10.1111/bph.12323
10
Xingjun Liu, Han Hu, James Q. Yin. Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosisLiver International 2006; 26(1): 8 doi: 10.1111/j.1478-3231.2005.01192.x
11
Rossana C. Perez Aguilar, Stella M. Honoré, Susana B. Genta, Sara S. Sánchez. Hepatic fibrogenesis and transforming growth factor/Smad signaling activation in rats chronically exposed to low doses of leadJournal of Applied Toxicology 2014; 34(12): 1320 doi: 10.1002/jat.2955